111 related articles for article (PubMed ID: 15210850)
21. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
Wright P; Zheng C; Moyana T; Xiang J
Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
24. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
Wang XY; Martiniello-Wilks R; Shaw JM; Ho T; Coulston N; Cooke-Yarborough C; Molloy PL; Cameron F; Moghaddam M; Lockett TJ; Webster LK; Smith IK; Both GW; Russell PJ
Gene Ther; 2004 Nov; 11(21):1559-67. PubMed ID: 15343359
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral low-volume jet-injection for efficient nonviral gene transfer.
Walther W; Stein U; Fichtner I; Voss C; Schmidt T; Schleef M; Nellessen T; Schlag PM
Mol Biotechnol; 2002 Jun; 21(2):105-15. PubMed ID: 12059110
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
[TBL] [Abstract][Full Text] [Related]
28. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.
Takakuwa K; Fujita K; Kikuchi A; Sugaya S; Yahata T; Aida H; Kurabayashi T; Hasegawa I; Tanaka K
Jpn J Cancer Res; 1997 Feb; 88(2):166-75. PubMed ID: 9119745
[TBL] [Abstract][Full Text] [Related]
29. Induction of Oxidants Distinguishes Susceptibility of Prostate Carcinoma Cell Lines to p53 Gene Transfer Mediated by an Improved Adenoviral Vector.
Tamura RE; Hunger A; Fernandes DC; Laurindo FR; Costanzi-Strauss E; Strauss BE
Hum Gene Ther; 2017 Aug; 28(8):639-653. PubMed ID: 28181816
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.
Gridley DS; Timiryasova TM; Miller GM; Andres ML; Dutta-Roy R; Bayeta EJ; Fodor I
Technol Cancer Res Treat; 2003 Feb; 2(1):41-50. PubMed ID: 12625753
[TBL] [Abstract][Full Text] [Related]
31. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
Furukawa K; Ohashi T; Haruki K; Fujiwara Y; Iida T; Shiba H; Uwagawa T; Kobayashi H; Yanaga K
Cancer Lett; 2011 Jul; 306(1):92-8. PubMed ID: 21482023
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
[TBL] [Abstract][Full Text] [Related]
33. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
[TBL] [Abstract][Full Text] [Related]
34. Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.
Tandle A; Hanna E; Lorang D; Hajitou A; Moya CA; Pasqualini R; Arap W; Adem A; Starker E; Hewitt S; Libutti SK
Cancer; 2009 Jan; 115(1):128-39. PubMed ID: 19090007
[TBL] [Abstract][Full Text] [Related]
35. Low-volume jet injection for efficient nonviral in vivo gene transfer.
Walther W; Stein U; Fichtner I; Schlag PM
Mol Biotechnol; 2004 Oct; 28(2):121-8. PubMed ID: 15477651
[TBL] [Abstract][Full Text] [Related]
36. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.
Tamura RE; da Silva Soares RB; Costanzi-Strauss E; Strauss BE
Cancer Biol Ther; 2016 Dec; 17(12):1221-1230. PubMed ID: 27646031
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of antitumor effects following tumor necrosis factor-α gene delivery using nanobubbles and ultrasound.
Horie S; Watanabe Y; Ono M; Mori S; Kodama T
Cancer Sci; 2011 Nov; 102(11):2082-9. PubMed ID: 21824220
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.
Al Robaian M; Chiam KY; Blatchford DR; Dufès C
Nanomedicine (Lond); 2014 Apr; 9(4):421-34. PubMed ID: 24910874
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: gene transfer by electroporation.
Mikata K; Uemura H; Ohuchi H; Ohta S; Nagashima Y; Kubota Y
Mol Cancer Ther; 2002 Feb; 1(4):247-52. PubMed ID: 12467220
[TBL] [Abstract][Full Text] [Related]
40. Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors.
Piccirillo CA; Prud'homme GJ
Hum Gene Ther; 1999 Aug; 10(12):1915-22. PubMed ID: 10466625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]